A second Kobayashi Pharma Japan factory inspected over deaths
© Reuters. Kobayashi Pharmaceutical Co. President Akihiro Kobayashi attends a press conference in Osaka, Japan March 29, 2024, in this photo taken by Kyodo. Mandatory credit Kyodo/via REUTERSTOKYO - Health authorities searched a second Kobayashi Pharmaceutical factory in western Japan on Sunday after the company reported five deaths possibly tied to dietary supplements, an official said.
As of Friday, 114 people had been hospitalised and five had died after taking the supplements, which were marketed as helping lower cholesterol levels, the company said. "We will fully cooperate with the investigation so that we can resolve the problems as early as possible," the head of Kobayashi's investor relations, Yuko Tomiyama, told reporters on Sunday in footage shown by public broadcaster NHK.
The government has criticised the company for taking two months to announce the health impacts of its products. Kobayashi began recalling products on March 22 after receiving reports of kidney ailments.Japanese media said a case of acute renal failure had been reported in Taiwan. Taiwan's food and drug administration is investigating three"unexpected health reactions" that may be related to imported materials from Kobayashi, Taiwan's official Central News Agency reported.
United Kingdom Latest News, United Kingdom Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Kobayashi Pharma Ordered to Recall Red Yeast Rice Pills After 2 DeathsJapanese authorities on Wednesday ordered drugmaker Kobayashi Pharmaceutical to recall three dietary supplement products containing red yeast rice, or beni koji, after they...
Read more »
Fix Japan’s work culture to fix Japan’s birth rateIt is still possible for a population in decline even as severely as Japan’s to recover, but it requires serious cultural reexamination.
Read more »
Kobayashi factory searched over deaths possibly linked to supplementsKobayashi factory searched over deaths possibly linked to supplements
Read more »
From 'Speed Dating' To ‘Pull’ Strategies: Pharma-Biotech CollaborationBy Carl Foster, CBO, Standigm. Read Carl T. Foster's full executive profile here.
Read more »
AstraZeneca bets on new cancer treatments with $2 billion Fusion Pharma purchaseThe deal is AstraZeneca's second this month after it agreed last week to buy Amolyt Pharma for $1.05 billion to shore up its rare disease portfolio.
Read more »
Cencora, a massive pharma distributor based in Conshohocken, announces CEO succession planThe company's chief operating officer Robert P. Mauch will take over on Oct. 1 from the retiring Steven Collis.
Read more »